Hesperos, Inc
Publicly observedOrlando, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Orlando | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Hesperos, Inc | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | R1LSLA5YJMJ9 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Sept 2026Publicly observed
NIH SBIR/STTR award: Expanded implementation of a human-based Malaria-on-a-Chip phenotypic disease model for the evaluation of therapeutic efficacy and off-target toxicity
USD 1,000,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant24 Apr 2024Publicly observed
NIH SBIR/STTR award: Human Neuromuscular Junction Platform to Evaluate Botulinum Toxin Potency
USD 720,882.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant24 Apr 2024Publicly observed
NIH SBIR/STTR award: Human NeuromuscularJunction Platform to Evaluate Botulinum Toxin Potency
USD 1,000,000.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant15 Aug 2021Publicly observed
NIH SBIR/STTR award: Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Anticholinergic Drug Induced Dementia
USD 1,499,996.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)
- Grant15 Aug 2021Publicly observed
NIH SBIR/STTR award: Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Anticholinergic Drug Induced Dementia
USD 1,500,000.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.